Back to Agenda
ICMRA – The Future of Medicines and Challenges for International Regulators
Session Chair(s)
Ian Hudson
Senior Advisor, Integrated Development
Bill and Melinda Gates Foundation, United States
The International Coalition of Medicines Regulatory Authorities (ICMRA) will explore some of the key challenges and opportunities for medicines regulation presented by emerging technologies and novel pathways across the international landscape. The session will be delivered by members of ICMRA’s Executive Committee who represent the European medicines regulatory system, including a number of leading regulators. Presentations will include examples drawn from members’ current experience of emerging technologies and an overview of ICMRA’s strategic priorities moving forward, including artificial intelligence, software, ATMPs and 3D printing. The session will conclude with a panel discussion of questions raised by the audience.
Speaker(s)
A Brief Introduction to ICMRA
Ian Hudson
Bill and Melinda Gates Foundation, United States
Senior Advisor, Integrated Development
Overview of ICMRA’s Strategic Priorities
Supriya Sharma, MD, MPH, FRCPC
Health Canada, Canada
Chief Medical Advisor
Example of Emerging Technologies - ATMPs
Tatsuya Kondo, MD, PhD
SH Medical Excellence JAPAN, Japan
President
Example of Emerging Technologies – Digital, Artificial Intelligence/Software
Rita Purcell, LLM
Health Products Regulatory Authority (HPRA), Ireland
Deputy Chief Executive
Example of Emerging Technologies – 3D Printing
John Skerritt, PhD
University of Melbourne, Australia
Enterprise Professor, Health Research Impact
ICMRA Moving Forward – The ‘Innovation’ Priority Project
Rita Purcell, LLM
Health Products Regulatory Authority (HPRA), Ireland
Deputy Chief Executive
Panel Discussion
Agnès Saint-Raymond, DrMed
European Medicines Agency, Netherlands
Head of Division International Affairs
Have an account?